Sistema de Salut de Catalunya
Institut Català de la Salut
[Muraro A] Padua University Hospital, Padua, Italy. [de Silva D] The Evidence Centre, London, UK. [Podesta M] European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium. [Anagnostou A] Children's Hospital, Houston, Texas, USA. Baylor College of Medicine, Houston, Texas, USA. [Cardona V] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Halken S] Hans Christian Andersen Children's Hospital and University of Southern Denmark, Odense, Denmark
Vall d'Hebron Barcelona Hospital Campus
2025-01-21T09:36:13Z
2025-01-21T09:36:13Z
2024-12
Adrenaline; Allergy; Anaphylaxis
Adrenalina; Al·lèrgia; Anafilaxi
Adrenalina; Alergia; Anafilaxia
This Anaphylaxis Manifesto calls on communities to prioritise 10 practical actions to improve the lives of people at risk of serious allergic reactions. The Global Allergy and Asthma European Network and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA) compiled patient-centric priorities. We used qualitative consensus methods, research evidence and feedback from over 200 patient groups, stakeholder organisations and healthcare professionals. We encourage healthcare, education and food organisations to collaborate with people at risk of serious allergic reactions to tackle safety, anxiety and financial burdens for individuals and societies. Key priorities for prevention include awareness-raising campaigns for the public and professionals, school and workplace initiatives and mandatory precautionary allergen labels on food. Priorities for improving immediate and long-term management include educating healthcare professionals, patients and schools about when and how to use adrenaline, funding two approved adrenaline devices for everyone at risk, and facilitating access to allergy specialists. Integrated care pathways should include clinical and non-clinical management options such as individualised risk assessment and quality of life assessment, self-management plans, dietetic and psychosocial support and peer support. Organisations around the world are committing to work together towards these priorities.
Global Allergy and Asthma European Network
Article
Published version
English
Anafilaxi - Tractament; Anafilaxi - Prevenció; Al·lèrgia; Educació sanitària; DISEASES::Immune System Diseases::Hypersensitivity::Hypersensitivity, Immediate::Anaphylaxis; Other subheadings::Other subheadings::Other subheadings::/prevention & control; HEALTH CARE::Population Characteristics::Health::Public Health; CHEMICALS AND DRUGS::Organic Chemicals::Alcohols::Amino Alcohols::Ethanolamines::Epinephrine; DISEASES::Immune System Diseases::Hypersensitivity; ENFERMEDADES::enfermedades del sistema inmune::hipersensibilidad::hipersensibilidad inmediata::anafilaxia; Otros calificadores::Otros calificadores::Otros calificadores::/prevención & control; ATENCIÓN DE SALUD::instalaciones, servicios y personal de asistencia sanitaria::servicios de salud::servicios preventivos de salud::educación en salud; COMPUESTOS QUÍMICOS Y DROGAS::compuestos orgánicos::alcoholes::alcoholes amino::etanolaminas::epinefrina; ENFERMEDADES::enfermedades del sistema inmune::hipersensibilidad
Wiley
Clinical and Translational Allergy;14(12)
https://doi.org/10.1002/clt2.70009
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3440]
